Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare. The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry. Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.

Share:
More In Science
The Unforeseen Consequences of the American Interstate System
Eisenhower’s interstate system was the biggest infrastructure project of its time. What justified the cost was its potential to connect all corners of America, but the unforeseen impacts of the highway system seemed to do the opposite of the intention.
First Recovered Meteorite in UK for 30 years
Fragments of a rare meteorite have been discovered in an English village. The discovery comes after residents were urged to check their gardens and neighborhoods after a meteor was seen shooting through the night sky last month.
Load More